Fingerprint
Dive into the research topics of 'TAK228 enhances antitumor activity of eribulin in triple negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
TAK228 enhances antitumor activity of eribulin in triple negative breast cancer
Nicci Owusu-Brackett, Kurt W. Evans, Argun Akcakanat, Erkan Yuca, Coya Tapia, Yasmeen Qamar Rizvi, Ecaterina Ileana Dumbrava, Filip Janku, Funda Meric-Bernstam
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations